Participated in Katalyze AI's $10.5M seed round for agentic AI in pharmaceutical manufacturing.
Katalyze accelerates the science that becomes the world's medicine, by freeing scientists and engineers from operational drag, using advanced AI agents for pharmaceutical operations
Katalyze accelerates the science that becomes the world's medicine, by freeing scientists and engineers from operational drag, using advanced AI agents for pharmaceutical operations.